The efficacy of this testing in a coordinated manner, with the use of best performing antibodies, rather than those approved for companion or complementary diagnostic testing, may provide a better and more consistent understanding of the tumor and immune cell expression of PD-L1. Here, CD274 is linked to neoplasm.